BIORESTORATIVE THERAPIES, INC.

(BRTX)
  Report
Delayed Nasdaq  -  05/18 03:59:51 pm EDT
3.750 USD   +2.74%
05/16BioRestorative Therapies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/16BIORESTORATIVE THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
05/05Certain Common Stock of BioRestorative Therapies, Inc. are subject to a Lock-Up Agreement Ending on 5-MAY-2022.
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

After Hours Watch List Scorecard: BRTX, AIR, CAMP

12/22/2021 | 05:16pm EDT


ę MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
AAR CORP. -2.08% 46.16 Delayed Quote.18.27%
BIORESTORATIVE THERAPIES, INC. 2.74% 3.75 Delayed Quote.-13.59%
CALAMP CORP. 3.69% 5.9 Delayed Quote.-19.41%
All news about BIORESTORATIVE THERAPIES, INC.
05/16BioRestorative Therapies, Inc. Reports Earnings Results for the First Quarter Ended Mar..
CI
05/16BIORESTORATIVE THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
05/05Certain Common Stock of BioRestorative Therapies, Inc. are subject to a Lock-Up Agreeme..
CI
04/29BioRestorative Therapies Hosts Principal Investigator Meeting for its BRTX-100« Phase 2..
GL
04/18BioRestorative Therapies Picks 10 US Clinical Sites for Trial of Spine Condition Treatm..
MT
04/18BioRestorative Therapies Announces Selection of 10 Clinical Sites for its Phase 2 Clini..
AQ
04/18BioRestorative Therapies, Inc. Announces Selection of 10 Clinical Sites for its Phase 2..
CI
04/07INSIDER BUY : BioRestorative Therapies
MT
04/04BioRestorative Therapies Announces cGMP Cell Manufacturing Facility Certification
AQ
03/30BIORESTORATIVE THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
More news
Analyst Recommendations on BIORESTORATIVE THERAPIES, INC.
More recommendations
Financials (USD)
Sales 2022 - - -
Net income 2022 -7,85 M - -
Net Debt 2022 - - -
P/E ratio 2022 -1,75x
Yield 2022 -
Capitalization 13,6 M 13,6 M -
Capi. / Sales 2022 -
Capi. / Sales 2023 -
Nbr of Employees 7
Free-Float 73,0%
Chart BIORESTORATIVE THERAPIES, INC.
Duration : Period :
BioRestorative Therapies, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 3,75 $
Average target price 37,00 $
Spread / Average Target 887%
EPS Revisions
Managers and Directors
Lance Alstodt Chairman, President & Chief Executive Officer
Robert E. Kristal Chief Financial Officer
Francisco J. Silva Secretary, Director & VP-Research & Development
Robert Paccasassi Vice President-Quality & Compliance
Patrick F. Williams Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BIORESTORATIVE THERAPIES, INC.-13.59%13
GILEAD SCIENCES, INC.-12.93%79 248
REGENERON PHARMACEUTICALS, INC.4.38%71 927
VERTEX PHARMACEUTICALS14.91%66 967
WUXI APPTEC CO., LTD.-18.77%42 682
BIONTECH SE-38.01%38 834